Venture Pulse Q3 2017

Highlights from the Venture Pulse Q3 2017 report

• The VC market remained strong in the U.S. during Q3’17, despite an ongoing decline in the total number of deals. 
  
  
• Healthcare, pharmaceuticals, and biotech attracted significant funding in Q3’17, with related companies accounting for half of the largest VC deals in the U.S.
  
  
• To date, the IPO market in the U.S. has been stronger in 2017 relative to 2016.

For in-depth analysis of these topics and additional insight on venture investment for the quarter,

READ THE LATEST REPORT: Venture Pulse Q3 2017

The Pulse Series

Venture Pulse and The Pulse of Fintech

KPMG’s Pulse Series of quarterly reports analyze the latest global and regional investment trends and insights. Included in the reports are comprehensive analyses on the lifecycle of venture capital investments as well as overall fintech investment across the Americas, Europe, and Asia. Each quarter we share the latest valuations, financing, deal sizes, mergers & acquisitions, exits, corporate investment, and industry trends.

KPMG's Venture Capital practice

KPMG’s Venture Capital (VC) practice offers a range of audit, tax and advisory services tailored to help venture-backed companies navigate each stage of development—from idea through exit. We use our knowledge of the VC ecosystem to help entrepreneurial ventures simplify the complex challenges of creating the technologies of tomorrow in highly competitive industries, while also meeting diverse regulatory, compliance, and financial reporting requirements. Our VC clients collaborate with a global network of KPMG professionals who understand the marketplace challenges facing start-ups and growth companies. Our passion and mindset match the companies we serve: entrepreneurial, hands-on, proactive, visionary, and dedicated.